VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650973
Sex: F
Age:
State: MA

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Body sore; This is a spontaneous report from a contactable consumer. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration on 27Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control, for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on 06Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 28Apr2021, the patient experienced body sore. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body sore was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650974
Sex: M
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: He received the covid vaccine, and then got up the next morning his leg was semi numb. Clarifies that it is not his entire left leg. He only has numbness in the front and back of his calf.; He feels breathlessness whenever he is lifting things. He gets more tired than before.; He feels breathlessness whenever he is lifting things. He gets more tired than before.; This is a spontaneous report from a contactable consumer (Patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: ER2613), Solution for injection, via an unspecified route of administration, administered in Deltoid Left on 07Apr2021 around 2:00 to 3:00PM as single dose for covid-19 immunisation. Medical history was reported as none. Family history included heart disease, Alzheimer's and Diabetes. The patient's concomitant medications were not reported. No additional vaccines administered on same date of the Pfizer suspect. Patient did not receive any vaccine within four weeks prior to Pfizer suspect. The patient received the covid vaccine, and then got up the next morning on 08Apr2021, his leg was semi numb. Clarified that it was not his entire left leg. He only had numbness in the front and back of his calf also he felt breathlessness whenever he was lifting things. He got more tired than before. Patient noticed that numbness was getting worse whenever he was walking. He had not been doing any strenuous exercise. Whenever they gave him the covid vaccine in his left shoulder, it was pretty painless. He did not think that his semi leg numbness and the covid vaccine were related. His leg numbness was not that intense. He described that it feels like, if someone was to do a lot of squats, and then feel numb. That was the exact feeling, and it was annoying. He also felt breathlessness whenever he was lifting things. He got more tired than before. He was concerned about getting the second dose, because he did not want his symptoms to get worse. He was not taking any medications. He had no medical history. He did not require to visit emergency room or Physician office due to adverse events. He was scheduled to receive his second dose of the covid vaccine on 28Apr2021. The outcome of events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650975
Sex: F
Age:
State:

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: She is experiencing fever, coughing and sneezing; She is experiencing fever, coughing and sneezing; She is experiencing fever, coughing and sneezing; This is a spontaneous report from a contactable female consumer (patient) reported for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), via an unspecified route of administration on 25Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. The patient experienced fever, coughing and sneezing. Patient wants to reschedule 2nd dose appointment due tomorrow on 27Apr, because patient was experiencing fever, coughing and sneezing. The outcome of the events were unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650976
Sex: F
Age:
State: AL

Vax Date: 04/07/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Cycle was shortened by about 4 days. Cycle generally runs like clockwork every 25 days, but period came 4 days earlier than usual.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 12:00, the patient's cycle was shortened by about 4 days. Her cycle generally runs like clockwork every 25 days, but her period came 4 days earlier than usual. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event cycle was shortened by about 4 days was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650977
Sex: M
Age:
State: IL

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210423; Test Name: Body Temperature; Result Unstructured Data: Test Result:100 Units:[degF]; Comments: high fever (100F)

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: apparent "superclavicular" swelling; apparent "superclavicular" swelling and pain in that region; high fever (100 F); This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 12:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, "hypotheroidism" and high cholesterol. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 01Apr2021 at 12:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Apr2021 at 09:00, the patient experienced apparent "superclavicular" swelling and pain in that region and high fever (100 F). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events apparent "superclavicular" swelling and apparent "superclavicular" swelling pain in that region and high fever (100 F) were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; ENALAPRIL; LEVOTHYROXINE; AMLODIPINE

Current Illness:

ID: 1650978
Sex: F
Age:
State: CT

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Cough; closed throat; swollen tongue; This is a spontaneous report from a contactable consumer (patient). A 56-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0151), via an unspecified route on 08Apr2021 at 09:45 (at the age of 56-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included known allergies. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 10:45, the patient experienced cough, closed throat, swollen tongue. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment for events with Benadryl. The outcome of the events was resolved on unspecified date of 2021. No follow-up attempt are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650979
Sex: F
Age:
State: CA

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210428; Test Name: Body temperature; Result Unstructured Data: Test Result:102.8 Units:{DF}; Comments: at 06:30

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Fever of 102.8; Sore arm; Cough; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to egg. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 06:30, the patient experienced fever of 102.8, sore arm and cough on second shot. On 28Apr2021 at 06:30, the patient underwent body temperature and the result was 102.8 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever of 102.8, sore arm and cough was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650980
Sex: M
Age:
State: WA

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Vomiting repeatedly; fever; arm pain; tiredness; headache; not drinking water; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 27Apr2021 at 12:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety, Attention Deficit Hyperactivity Disorder (ADHD) and asthma. The patient had no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC), clonidine (MANUFACTURER UNKNOWN), budesonide (NASOCORT) and levocetirizine dihydrochloride (XYZAL), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 04:00, the patient experienced vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water. The clinical outcome of the events vomiting repeatedly, fever, arm pain, tiredness, headache and was not drinking water were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; CLONIDINE; NASOCORT; XYZAL

Current Illness:

ID: 1650981
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Numbness in feet and lower legs/numbness in my feet and my lower extremities; This is a spontaneous report from a contactable consumer(patient). A 63-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration, administered in Arm Right on an unspecified date as dose 1, single for covid-19 immunization. Medical history included breast cancer from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no known allergies. Pregnant at the time of vaccination was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 15Apr2021 the patient stated, she was calling because she had numbness in her feet and her lower extremities after getting the vaccine and she wanted to know if anybody else was experiencing these symptoms as well. When clarified the concern, patient stated, Numbness in her lower leg and in her feet and she wanted to know if other people are experiencing these symptoms. The Ae resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment received for the adverse event was reported as no. The clinical outcome of event was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650982
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: This is a spontaneous report from a contactable consumer. A 80-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6201, expiration date not reported), via an unspecified route of administration, on Mar 8, 2021, single dose, for COVID-19 immunisation. Medical history included COVID-19 from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had no other vaccine in four weeks. Historical vaccine included the flu vaccine (formulation, batch/lot# and expiration date not reported), via an unspecified route of administration, on an unspecified date of 1957, for an unknown indication and had a violent reaction to flu vaccine. Patient has not tested for COVID-19, post vaccination. On Mar 14, 2021, patient had a thickened tongue towards back of throat that did not impede breathing. On Mar 18, 2021, patient's chin blew-up to size of 2 grapefruits. She had no appetite and no energy. On Mar 22, 2021, patient saw the dentist and got amoxicillin for 7 days. On Apr 13, 2021, patient's chin again blew-up, but now it was the size of ? a grapefruit. She went to dental surgeon who stated it was not dental-related. On Apr 21, 2021, patient had an ache in her ears and throat. Again she had no energy. On Apr 28, 2021, patient felt better. Patient had doctor or other healthcare professional office/clinic visit for all the events. Treatment/therapeutic measures taken as a result of all the events included amoxicillin. The outcome of all the events: recovering. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1650983
Sex: F
Age:
State: LA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Patient started having cervical and thoracic sharp neck pain; Patient started having cervical and thoracic sharp neck pain; This is a spontaneous report from a contactable Physician. A 28-year-old non-pregnant female patient received unknown dose number of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via intramuscular route on an unspecified date in Apr2021 (at the age of 28-year-old) as single dose for COVID-19 immunization. Medical history of the patient included depression. Patient had no known allergies. Concomitant/other medications in two weeks included bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication. It was unknown if patient received any other vaccine in four weeks. It was unknown if patient had COVID prior vaccination and was not tested for COVID post vaccination. On an unspecified date in Apr2021, patient started having cervical and thoracic sharp neck pain. AE resulted in Doctor or other healthcare professional office/clinic visit. Treatment included NSAIDS and muscle relaxer. Outcome of the events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1650984
Sex: F
Age:
State: MN

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210416; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Rash, Urticaria

Symptoms: I have sudden symptoms of Urinary Tract Infection; extremely fatigued; develop upper respiratory congestion/discomfort; cough; This is a spontaneous report from a contactable consumer (patient herself). A 35-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8731, expiry date: unknown) via unspecified route of administration, in left arm on 08Apr2021 16:45 (age at vaccination: 35-years) as dose 1, single for Covid-19 immunisation. Facility type vaccine was public health clinic/veterans administration facility. Patient was not pregnant at the time of vaccination. Patients medical history included obese from an unspecified date and unknown if ongoing. Patient had no known allergies. Concomitant medications were not reported. No other vaccine in four weeks was administered. Other medications taken in two weeks was topical nail fungal treatment. Patient stated to date, she had received first dose of the Pfizer Covid vaccination. Within 1-2 days, on 10Apr2021, she was extremely fatigued. This did not resolve within a day or so as she anticipated. She then began to develop upper respiratory congestion/discomfort 4-5 days post vaccine. She was presently still congested, fatigued, and have a cough as of 21Apr2021, with little improvement. On 10Apr2021, she had sudden symptoms of urinary tract Infection. She did do an e-visit for antibiotics to address the UTI. She had not been seen for the upper respiratory symptoms yet, but may go in if they persist into next week. AE resulted in doctor or other healthcare professional office/clinic visit. Nitro FU Rantoin macro crystal monohydrate 100 MG cap was given as treatment for the adverse events. Patient had not been diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. Patient underwent nasal swab (SARS-CoV-2 test) with negative results on 16Apr2021. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650985
Sex: F
Age:
State:

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Heart rhythm went berserk, my heart was just pounding and it was even slamming into my back; there is not one incidence of anything with my heart until I took this shot; my heart speed is up; I did not take the second shot; I am extremely sensitive\I had severe reaction; I was too sick; \This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (COMIRANTY; Formulation: Solution for injection; Lot number: Unknown, Expiration date: Unknown, Age at vaccination: 70-year-old) via an unspecified route of administration in left arm on 12Mar2021 11:00 as dose 1, single for COVID-19 immunization. Medical history included menopause. Concomitant medications included Estrogen and Progesterone. On an unspecified date patient stated, heart rhythm went berserk, heart was just pounding and it was even slamming into my back; there was not one incidence of anything with my heart until patient took this shot; heart speed is up, patient was extremely sensitive and had severe reaction, sickness and did not take second shot. Patient had the first shot of the Pfizer Vaccine on 12March, it was like 6 weeks ago it was on Friday morning about 11 'O' clock, then Sunday morning within 36 hours took that shot my heart rhythm went berserk, heart was just pounding and it was even slamming into my back. Patient was needed to find out what was that. Patient did not take the second shot because didn't know what would happen to me, I went to the ER twice in one week. The first week I have been on a holter monitor the heart monitor for 14 days, Patient was on a beta blocker too twice a day to slow my heart beat down, had EKG in first saw the cardiologist. Patient didn't have any immediate allergic reactions or anything, but it was like within 36 hours and I am 70 year old and I have never had a heart issue in my life. Sunday morning at 4, 5 'O' clock in the morning it was early in the morning I woke up like that my heart was pounding, wanted to calm down. The only thing that happened to me is that my heart speed is up. Patient stated, "she was taking beta blockers that's supposed to slow your heart down, that's what cardiologist gave me." Lab test included blood work. The outcome of all events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ESTROGEN; PROGESTERONE

Current Illness:

ID: 1650986
Sex: F
Age:
State: OR

Vax Date:
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Test Name: EMG; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Tingling in extremities; Feeling of heaviness in limbs; Weakness and cramping throughout body; Brain fog; Weakness and cramping throughout body; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) for an unspecified indication, from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1383) via an unspecified route of administration in the left arm on 14Jan2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced tingling in extremities, feeling of heaviness in limbs, weakness and cramping throughout body and brain fog. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures, which included Electromyography (EMG), Magnetic resonance imaging (MRI) and the results were unknown. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included lab tests and referred to vascular. The clinical outcome of event tingling in extremities, feeling of heaviness in limbs, weakness and cramping throughout body and brain fog were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAZODONE

Current Illness:

ID: 1650987
Sex: F
Age:
State: MI

Vax Date: 04/01/2021
Onset Date: 04/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: I had blurred vision the first day; ear aches; body aches; have not stopped bleeding; had lots of blood clots; I've been menstrating for 2 weeks straight, a week extra; This is a spontaneous report from a contactable consumer (Patient). A 46-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8730, Expiration date was not reported), via an unspecified route of administration, administered in Arm Right on 01Apr2021 14:00 (age at vaccination was 46 years) as dose 1, single and dose 1 via an unspecified route of administration, administered in Arm Right on 01Apr2021 (Lot Number: EW0162) as dose 1, single for Covid-19 immunization. Medical history included Alpha thalassemia minor carrier, Anxiety /depression, ongoing Menorrhagia, Known allergies: Penicillin allergy. Concomitant medication(s) included escitalopram oxalate (LEXAPRO); bupropion hcl (BUPROPION HCL); one a day allergy; naphazoline hydrochloride (ALLERGY [NAPHAZOLINE HYDROCHLORIDE]); calcium carbonate, colecalciferol (CALCIU D3). Prior to vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient had not been tested for Covid-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 16:00 the patient reported blurred vision the first day, ear aches, body aches, have not stopped bleeding, had lots of blood clots, she has been menstruating for 2 weeks straight, a week extra. She do have menorrhagia but this is not usual for me to have so many clots and bleeding that has not lightened. so she had been menstruating for 2 weeks straight, a week extra. Patient did not receive any treatment for occurred event. The outcome of events was not resolved. Follow-up (19Jul2021): Follow-up attempts completed. No further information expected.

Other Meds: LEXAPRO; BUPROPION HCL; ALLERGY [NAPHAZOLINE HYDROCHLORIDE]; CALCIU D3

Current Illness: Menorrhagia (I do have Menorrhagia)

ID: 1650988
Sex: F
Age:
State: FL

Vax Date: 04/02/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Menstrual cycle dysregulated; Delayed period; Bled very heavily; This is a spontaneous report from a contactable other healthcare professional, the patient. This is the first of two reports. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 02Apr2021 at 18:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. No concomitant medications were reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021, the patient experienced menstrual cycle dysregulated. The patient reported that her cycle was due on the day of the first dose but it was delayed by 7 days and once it initiated, she bled very heavily on 09Apr2021. The patient reported that she had a regular 26-to-28-day cycle prior to the vaccine. The clinical outcome of the event menstrual cycle dysregulated, delayed period and bled very heavily was not resolved at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650989
Sex: F
Age:
State: IL

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: COVID-19 antibody test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Reiterated her physician advised her not to get the second COVID-19 Vaccine; High fever; an intense headache; Fatigue; Swelling of injection site; This is a spontaneous report from a contactable consumer (patient herself). A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EM9809, expiry date: unknown) via unspecified route of administration, administered in left arm on 17Feb2021 11:30 (age at vaccination: 65-years) as dose 1, single for COVID-19 immunisation. Vaccine was not administered at facility. There was no history of all previously immunizations and no other vaccines was administered on the same day of covid vaccine. There was no prior vaccinations within 4 weeks and no AEs following prior vaccinations. Family medical history was none. Patients medical history and concomitant medications were not reported. Patient was supposed to receive second dose, she thinks 10Mar2021. She developed a reaction from the vaccine during the first week after getting the first dose. She clarified as a high fever, an intense headache that she couldn't get rid of, and fatigue. She reported her symptoms to her personal physician and around that time he had caller take an antibody test. She was positive for antibodies. Her physician preferred to not receive the second vaccine. It went very well. She just reported her symptoms to her physician rather than Pfizer or the department of public health. She received a letter from Public Health wanting to know if she didn't get the second vaccine to please get it. So she wanted to report and let Pfizer know as to why she didn't get it. She was appreciative that Pfizer received emergency use for the vaccine and had helped a lot of people. High Fever began probably around 03:00 on 18Feb2021, temperature was 101. She was taking Tylenol for it. It lasted for a couple of days. Intense headache which she couldn't get rid of began probably around 03:00 on 18Feb2021. Headache seemed intense for the first couple of days. Then went to a dull headache for like five days. Personally she doesn't do well with headaches and doesn't usually get headaches. It was unusual for her. She was just really tired on 18Feb2021. It lasted about a week, about seven days. She had swelling in her injection site more towards the evening of 17Feb2021. She applied cold compresses on it and it went down. Confirmed swelling has subsided. Patient stated she was positive for Covid-19 antibodies. She was granted emergency usage in Jan2021. She asked if that date was correct. Patient called her local health department to be put on the list when her age group came up. She was called in a couple of weeks. She confirmed COVID-19 antibody test was performed after she received the first dose of COVID-19 Vaccine. She does not remember exact date of the antibody blood test. Reiterated her physician advised her not to get the second COVID-19 Vaccine. The patient underwent lab test for COVID-19 antibody test with positive results on an unspecified date. The outcome of the events was recovered for high fever, an intense headache and fatigue on an unspecified date in 2021 and swelling of injection site on 18Feb2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650990
Sex: M
Age:
State:

Vax Date: 04/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: vaccination occurred 5-6 Drops of blood from the infection site; This is a spontaneous report from a contactable consumer (patient) based on information received by Pfizer from BioNTech (manufacturer control number:46597), license party for (Comirnaty). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 23Apr2021 (Batch/Lot Number: EW0153) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced vaccination occurred 5-6 drops of blood from the infection site on an unspecified date. The outcome of event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650991
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: fever; This is a spontaneous report from a program. A contactable female consumer reported for herself. A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that there was a call from a caller who has already received her first dose of the vaccine and wanted to be scheduled for second dose. Caller stated that she is also experiencing fever and wanted to know if she will go through that with the second dose. The outcome of the event was unknown. No follow-up attempts are needed. information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650992
Sex: F
Age:
State: CO

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:low grade

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: I have had moderate to severe diarrhea; low grade fever; low energy; This is a spontaneous report from a contactable other hcp (patient). A 55-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 22Apr2021 14:15 (at the age of 55 years), (Batch/Lot Number: EW0171) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included High blood pressure, covid-19 from an unknown date and unknown if ongoing. Concomitant medications included ascorbic acid (VITAMINS C), vitamin d nos, zinc, levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO) and pitavastatin calcium (LIVALO) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 19:00, the patient experienced moderate to severe diarrhea that began about 5 hours after receiving the vaccine. She also had a low-grade fever in the evenings and low energy. The events resulted in the visit to Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: low grade on an unspecified date. If the patient received any treatment for the adverse events was unknown. The clinical outcome of the events was not recovered at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMINS C; VITAMIN D NOS; ZINC; SYNTHROID; LEXAPRO; LIVALO

Current Illness:

ID: 1650993
Sex: F
Age:
State: PA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: had to start supplementing formula bc milk production dropped drastically; Exposure via Breast feeding; Exposure via Breast feeding; had menthol taste/feeling in mouth/throat; This is a spontaneous report from a contactable consumer (patient). A 36-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection and lot number: ER8727) via an unspecified route of administration, administered in arm right on 19Mar2021 08:15 (age at vaccination: 36-years-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing asthma. Concomitant medications included loratadine (CLARITINE), received within 2 weeks of vaccination. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient previously took dilaudid and had known allergies: Dilaudid. The vaccine exposure via Breast feeding on 19Mar2021 08:15. The patient experienced had menthol taste/feeling in mouth/throat on 19Mar2021. The patient had to start supplementing formula bc milk production dropped drastically on 21Mar2021. The patient was not received treatment for the events of had menthol taste/feeling in mouth/throat and had to start supplementing formula bc milk production dropped drastically. The outcome for the event of had menthol taste/feeling in mouth/throat was recovered on 20Mar2021 and other event of Lactation decreased was recovering. No follow up attempts are needed. No further information is expected.

Other Meds: CLARITINE

Current Illness: Asthmatic

ID: 1650994
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Temperature; Test Result: 103.3 {DF}

Allergies:

Symptom List: Unevaluable event

Symptoms: has a high temperature; This is a spontaneous report from a contactable consumer. A 51-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date the patient experienced high temperature, running a temperature of 103.3. Consumer stated that patient wasn't able to get treatment recommendations for fever from the company that manufactures the vaccine. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650995
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Red rash across chest; The left side of neck hurt and it still does 6 days later; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control and phentermine, both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient went back to work after shot and experienced a red rash across chest. Later that evening, the patient experienced left side of her neck hurt and it still persisted 6 days later. This concerned the patient as it didn't hurt prior to the shot. The patient's neck had always been fine until the time of report. The patient stated that the rash went away. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red rash across chest was recovered on an unknown date in Apr2021. While that of the event neck hurt was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PHENTERMINE

Current Illness:

ID: 1650996
Sex: F
Age:
State: TN

Vax Date: 01/26/2021
Onset Date: 03/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210127; Test Name: SARS-CoV2-PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Unexplainable ecchymosis on bilateral lower extremities; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 26Jan2021 at 10:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), escitalopram (MANUFACTURER UNKNOWN) and colecalciferol (vitamin D3) (MANUFACTURER UNKNOWN), all from unknown date, for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 26Jan2021 at 10:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 20Mar2021, the patient experienced unexplainable ecchymosis on bilateral lower extremities. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 27Jan2021, the patient underwent SARS-CoV2-PCR test and the result was negative. The clinical outcome of the event unexplainable ecchymosis on bilateral lower extremities was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; ESCITALOPRAM; VITAMIN D3

Current Illness:

ID: 1650997
Sex: F
Age:
State: OH

Vax Date: 04/14/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Depression, a deep depression/feling down for no reason; Feeling tired/super tired; Her arm is still sore; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Batch/Lot Number: ER8729) via an unspecified route of administration, administered in right arm on 14Apr2021 (at the age of 58-years-old) as Dose 2,Single for COVID-19 immunization. The patient's medical history included ongoing overweight gained 30 lbs , ex-tobacco user from 2020 and ongoing. The patient's concomitant medications were not reported. She experienced a deep depression that lasted a day and a half. She got the Pfizer COVID 19 vaccine last Wednesday 14Apr2021 and woke up Thursday 15Apr2021 feeling tired but stated that she expected that. Early in the afternoon on Thursday 15Apr2021 she began feeling down for no reason and couldn't put her finger on it, couldn't figure it out and didn't initially attribute it to the shot and she didn't know what this is. She experienced total detachment, didn't want to do anything, couldn't move around and even had to cancel plans for her birthday. The depression was so devastating she couldn't even shower. Stated that she is not the only person who experienced this side effect from what she understands. Thursday afternoon 15Apr2021 into Thursday night 15Apr2021 and all day Friday 16Apr2021 caller states she felt depressed. On Saturday 17Apr2021, she was finally able to move but it was a stretch because she had to go to grocery store so she had to push herself to go. She could push herself on Saturday 17Apr2021, and the feeling dissipated on Saturday 17Apr2021 and she was more herself on Sunday 18Apr2021. Her arm is still sore and that she had the shot done in the same arm because she figured she didn't want the other arm to hurt if it didn't have to. She used the right arm for both shots and it is very sore. She states that it is an exercise kind of sore, like lifting weights and feels like she has worked out a muscle that she hasn't worked in a while. She didn't read anything about the depression being a side effect and doesn't suffer with depression. Her experience has changed her outlook and respect for people who do have depression and take medications. She realized you can't just push yourself and when her girlfriend was diagnosed with depression caller was so cavalier about it. Her experience has given her some information that she had missed. She thinks it is important because depression isn't listed as a possible side effect. She had the shot on the 14Apr2021. She was perplexed and didn't know what was wrong she was feeling detached, couldn't do anything, couldn't leave the house, couldn't take a shower, couldn't cook, that the experience didn't take her appetite but it was horrible. Super tired physical feeling got better the afternoon of the 15th. She woke up that morning tired and had to call out from her job because she has to be on her game because she is a city bus driver. Even though she went to bed on time she had to call out and it felt like she got hit by a Mack truck. She reported tired feeling dissipated, and she slept up until 11:00 AM. The physical fatigue dissipated as the emotional and mental fatigue consumed her. She finally got up at 11:00 AM on 15Apr2021, she tried to get excited about the next day even though she was off of work. She noticed that her girlfriend called and noticed after the fact that something was going on because caller states that her girlfriend got on her nerves and caller was irritable at that point. She wanted was for her girlfriend to stop singing Happy Birthday to her. She got up about 11:00 AM on 15Apr2021 and was moving around about 12:00 PM. She started really feeling depressed about 1:00 PM that day 15Apr2021. She wanted to get on with her day, she wanted to celebrate being 58 years old for the last time ever but she couldn't. Saturday morning 17Apr2021 the depression started to dissipate and she could really function that afternoon. She had no experience with this feeling, nothing to reference it to. She wasn't 100% until Saturday evening 17Apr2021 / Sunday 18Apr2021 when she was able to get up and move around. She has recovered completely. Her husband didn't say anything but she states she knows she didn't smell so good, she couldn't do anything about it. The outcome for the event her arm is still sore was not recovered/not resolved and recovered/resolved for rest of the events. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021481511 same reporter/drug, similar AE, different patient;US-PFIZER INC-2021481530 same reporter/drug, similar AE, different patient

Other Meds:

Current Illness: Ex-smoker; Overweight (gained 30 lbs)

ID: 1650998
Sex: F
Age:
State: CT

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210423; Test Name: blood pressure; Result Unstructured Data: Test Result:165/85; Test Date: 20210423; Test Name: blood pressure; Result Unstructured Data: Test Result:Normal; Test Date: 20210423; Test Name: Heartbeat; Result Unstructured Data: Test Result:120 bmp; Test Date: 20210423; Test Name: Heartbeat; Result Unstructured Data: Test Result:Normal

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: rapid heartbeat (120bmp); high blood pressure (165/85); dizziness; lightheaded; This is a spontaneous report from a contactable consumer or other non hcp. A 45-years-old non-pregnant female patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration in Arm Right on 23Apr2021 12:30 (age at vaccination: 45 Years) as DOSE 1, SINGLE for covid-19 immunisation. Patient was not pregnant at the time of vaccination, Patient didn't receive other vaccines within 4 weeks prior to vaccination, patient had other medications Metoprolol, Lisinopril, Pepcid, Claritin, Melatonin within 2 weeks. Medical history included hypertension from an unknown date and unknown if ongoing, rubber sensitivity from an unknown date and unknown if ongoing. Concomitant medications included metoprolol (METOPROLOL) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; aluminium hydroxide gel, dried, magnesium carbonate (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) taken for an unspecified indication, start and stop date were not reported; clarithromycin (CLARITIN [CLARITHROMYCIN]) taken for an unspecified indication, start and stop date were not reported; melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported. Patient didn't had covid prior to vaccination. The patient previously took codeine and experienced drug hypersensitivity, avalox and experienced drug hypersensitivity and allergy to latex. On 23Apr2021 12:30 the patient experienced rapid heartbeat (120bmp), high blood pressure (165/85), dizziness, lightheaded. No treatment was received for the events. The patient underwent lab tests and procedures which included blood pressure measurement: 165/85 on 23Apr2021, blood pressure measurement: normal on 23Apr2021, heart rate: 120 bmp on 23Apr2021, heart rate: normal on 23Apr2021. Patient was not tested to covid to post vaccination. The outcome of the events heart rate increased, hypertension, dizziness was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: METOPROLOL; LISINOPRIL; PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]; CLARITIN [CLARITHROMYCIN]; MELATONIN

Current Illness:

ID: 1650999
Sex: M
Age:
State: NE

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: stated that he was not eating; has no sense of smell; has no sense of taste; drainage from his sinuses was out of control; Nauseated; throwing up; cough; has lost close to 20 pounds; This is a spontaneous report from a contactable consumer or other non hcp. A 69-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN6204; Expiration Date: 21Jul2021) via an unspecified route of administration in Arm Left on 05Mar2021 08:45 as single dose for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing He had shingles three years ago. The patient's concomitant medications were not reported. The patient experienced stated that he was not eating on an unspecified date, has lost close to 20 pounds on 05Mar2021 06:30, has no sense of smell, has no sense of taste on 15Mar2021 06:30, drainage from his sinuses was out of control, nauseated, throwing up, cough on 15Mar2021. Clinical course was reported as he started not eating 06 Mar or 07Mar. he could not smell so he could not eat. he has had so much drainage from his sinuses in past six weeks that he is getting nauseated and throwing everything up. Clarified had a reduced sense of smell in past three years since shingles but now has no sense of smell. he had drainage since shingles but that it has gotten out of control since the vaccine. he would cough so violently and then be in the bathroom throwing up. The clinical outcome of the event lost close to 20 pounds was unknown other events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651000
Sex: U
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: numbness in their limbs after receiving the first Covid 19 vaccine; This is a spontaneous report from a contactable consumer or other non hcp (patient) reported for a friend. A patient of an unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified the patient experienced numbness in their limbs after receiving the first covid 19 vaccine. This report is in reference to the patient that the reporter's friend mentioned in the first report. When the reporter was speaking of her own experience with the Covid 19 vaccine, she mentioned a patient that had a similar experience. One of the reporter's friends is a primary care doctor and the doctor saw the same type of reaction that the reporter had, in another patient. The reporter's friend who is a doctor mentioned someone that had numbness in their limbs after receiving the first Covid 19 vaccine. When this person had the second Covid 19 vaccine they had more numbness in their body and now they are hospitalized in hospital. That person is having a bad reaction. When probing for information regarding the other patient that experienced numbness after receiving the Covid 19 vaccine who is now hospitalized, the reporter reports she does not know anything about that person. Outcome of the event was unknown. No further information is provided or obtained. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651001
Sex: F
Age:
State: MA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever; body aches; pain that goes up her neck and behind her head; pain that goes up her neck and behind her head; This is a spontaneous report received from a contactable consumer (patient herself). A 64-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0151; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 06Apr2021 15:00 (at age of 64-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included ongoing hypertension; high blood pressure and blood cholesterol increased; high cholesterol, she was diagnosed last year. She has been taking pills for it since last year and ongoing thyroiditis. The patient's concomitant medications were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as no. Patient's medical history (including any illness at time of vaccination) was reported as no. Family medical history relevant to AE(s) was reported as no. Other products was reported as unknown. It was reported that on 07Apr2021 caller stated she had a fever; the next day after the vaccine, at 2 o'clock, she started feeling body aches, and thought she had a fever, too. She still felt a little pain in her neck- it was not much, but she can still feel it. She clarified the pain went up her neck and behind her head, and it was still there a little bit but she was taking Ibuprofen. Caller confirmed she did not have the Ibuprofen with her at the time of the call to provide product information, but stated it was 600 mg. She clarified the fever and body aches stopped after she took Ibuprofen and she also took a Tylenol then, too. The adverse event did not require visit to emergency room or physician office visit. Caller was calling about the COVID-19 Vaccine. Caller stated that she was supposed to have her second vaccine on 27Apr2021 but she thought it was yesterday, 28Apr2021. She stated that she missed her appointment and she needed to make another second appointment. Caller stated that she got the vaccine. She stated she called her doctor and they said that they have no vaccines at clinic to give out. The outcome of fever and body aches was resolved on 07Apr2021 while not recovered for other events. No further details were provided or obtained. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: High cholesterol (She has been taking pills for it since last year.); Hypertension (she was diagnosed last year); Thyroiditis

ID: 1651002
Sex: M
Age:
State: VA

Vax Date: 04/26/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Tiredness; fatigue; right eye itches/burning sensation; right eye itches/burning sensation,; right eye slightly blurred; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 26Apr2021 at 14:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (EQUATE ALLERGY RELIEF) for unspecified indication from unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the right arm on 05Apr2021 at 14:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 06:00, the patient experienced tiredness, fatigue, right eye itched/burning sensation and right eye slightly blurred. No therapeutic measures were taken as a result of these events. These events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events tiredness, fatigue, itchy eyes, burning sensation on eye and right eye slightly blurred was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CETIRIZINE HYDROCHLORIDE

Current Illness:

ID: 1651003
Sex: F
Age:
State: SC

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Grade 1 Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol (VIT D3), lysine (MANUFACTURER UNKNOWN), ascorbic acid; calcium carbonate; calcium pantothenate; calcium phosphate; chromium; cyanocobalamin; folic acid; magnesium carbonate; magnesium hydroxide; manganese gluconate; nicotinic acid; potassium bicarbonate; potassium carbonate; potassium phosphate dibasic;, pyridoxine hydrochloride; quercetin; riboflavin sodium phosphate; sodium bicarbonate; sodium phosphate; thiamine hydrochloride; thioctic acid; zinc ascorbate (EMERGEN C), cetirizine hydrochloride (ZYRTEC) and unspecified "MultiVit" ; all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Apr2021, the patient experienced grade 1 fatigue which lasted for 24 hours and was relieved by rest, started the day after the second dose was received. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event grade 1 fatigue was resolved on 25Apr2021 after a duration of 24 hours. No follow-up attempts are needed. No further information is expected.

Other Meds: VIT D3; LYSINE; EMERGEN C; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1651004
Sex: F
Age:
State: TX

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 40-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 40, via an unspecified route of administration, left arm, on Apr 7, 2021, at 09:30, single dose, for COVID-19 immunisation. The patient has no reported medical history. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Vitamin K2 (menaquinone), Vitamin D3 (cholecalciferol), Vitamin B12 (cyanocobalamin), magnesium and multivitamin. On Apr 7, 2021, at 10:15 (30 minutes after vaccination), patient's throat became itchy, the bottom of her tongue and back began to tingle and itch really bad. No therapeutic measures taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of the events throat became itchy, the bottom of her tongue and back began to tingle and itch really bad: unknown (at the time of this report). No follow-up attempts required. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds: Vitamin K2 (menaquinone); Vitamin D3; Vitamin B12; Magnesium: Multivitamin

Current Illness:

ID: 1651005
Sex: F
Age:
State: MI

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot number: EW0176) via intramuscular route of administration in the left arm on 29Apr2021 at 14:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and hypertension. The patient was allergic to fish (walleye). Concomitant medications included ZOLOFT, Omeprazole, Lisinopril-Hydrochlorothiazide, and Atorvastatin, all for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 05:00, the patient experienced moderate pain at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain at injection site was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; OMEPRAZOLE; LISINOPRIL/HCTZ; ATORVASTATIN

Current Illness:

ID: 1651006
Sex: F
Age:
State: IL

Vax Date: 04/28/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Fever; Chills; Headache; Body aches; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 11:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 22:00, the patient experienced fever, chills, headache, body aches, nausea and vomiting. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, headache, body aches, nausea and vomiting were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651007
Sex: F
Age:
State: CA

Vax Date: 04/23/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:99.5 degree

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: She is now experiencing a fever of 99.5 degrees; sneezing, nose is running, she feels like she has head colds; sneezing, nose is running, she feels like she has head colds; sneezing, nose is running, she feels like she has head colds; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) of an unspecified age received bnt162b2 (BNT162B2 Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021 patient was experiencing a fever of 99.5 degrees, sneezing, nose is running, she feels like she has head colds, but she never had colds for years. The patient underwent lab tests and procedures which included pyrexia: 99.5 degree. No unaddressed medical questions referred or forwarded to Medical Information. The outcome for all events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651008
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Numbness and tingling in L arm post Covid vaccine injection; tingling in L arm post Covid vaccine injection; This is a spontaneous report from a contactable other hcp (Nurse) (patient). This report was received via a sales representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on an unspecified date at dose number unknown, single for covid-19 immunisation. Medical history included numbness and tingling due to spinal cord compression. Concomitant medications were not reported. On an unspecified date the patient experienced numbness and tingling in L arm post covid vaccine injection. Description of Event: Numbness and tingling in L arm post Covid vaccine injection. Hx of numbness and tingling due to spinal cord compression. Event took place after use of product. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651009
Sex: F
Age:
State: IL

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Within 24 hrs of vaccine swelling in arm pit which increased in size and sensitivity over the course of 2 days, approximate size of a lemon. Swelling and sensitivity then decreased over a course of 2 days; Within 24 hrs of vaccine swelling in arm pit which increased in size and sensitivity over the course of 2 days, approximate size of a lemon. Swelling and sensitivity then decreased over a course of 2 days; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Other medical history and concomitant medications taken within two weeks of vaccination were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GP6955 6121) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 02:00, within 24 hours of vaccine, the patient experienced swelling in arm pit which increased in size and sensitivity over the course of two days, approximate size of a lemon. Swelling and sensitivity then decreased over a course of two days. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events within 24 hours of vaccine, experienced swelling in arm pit which increased in size and sensitivity over the course of two days, approximate size of a lemon; swelling and sensitivity then decreased over a course of two days was resolved on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1651010
Sex: F
Age:
State: NY

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210424; Test Name: heart rate; Result Unstructured Data: Test Result:low heart rate (47-51 BPM; Test Date: 20210429; Test Name: COVID-19 BY NAAT PCR, TMA,; Test Result: Negative ; Comments: COVID-19 BY NAAT PCR, TMA,; Test Date: 20210427; Test Name: Nasal swab; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210427; Test Name: PCR Test; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210427; Test Name: Rapid Test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: 5+ days of chest tightness; Low heart rate (47-51 BPM); Fatigue/Exhaustion; Headache; Nausea; Vomiting; Fibromayalgia symptoms; Diarrhea; Cold feet/hands; Muscle shaking; Confusion; Abdomen discomfort; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: EW0161) via an unspecified route of administration, administered in Arm Left on 23Apr2021 19:15 at the age of (26-years-old) as a dose 2, single for covid-19 immunization. Medical history included sjogren's syndrome, Hashimoto's, fibromyalgia, asthma, endometriosis, Penicillin allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Concomitant medication included hydroxychloroquine taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient did not diagnose with covid-19. Since the vaccination patient was not diagnosed with covid-19. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: ER8730) via an unspecified route of administration, administered on an unspecified date in mar2021 at 07:00 PM as a single dose for covid-19 immunisation. It was reported that on 24Apr2021 13:00 the patient experienced 5+ days of chest tightness, low heart rate (47-51 BPM), fatigue/exhaustion, headache, nausea, vomiting, Fibromyalgia symptoms, diarrhoea, cold feet/hands, muscle shaking, confusion, abdomen discomfort & joint pain. On 24Apr2021 the patient underwent lab tests and procedures which included heart rate which includes low heart rate (47-51 bpm), on 27Apr2021 Nasal Swab test: negative, PCR test: negative, Rapid Test: Negative Nasal Swab. On 29Apr2021 COVID-19 BY NAAT PCR, TMA: negative. The patient was recovering from the events. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYCHLOROQUINE

Current Illness:

ID: 1651011
Sex: F
Age:
State: TX

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Experiencing aching pain on injection site side of body( right); tender and moveable lump on collarbone; tender and moveable lump on collarbone; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 29Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021, the patient experienced aching pain on injection site side of body (right) and at night after the vaccine, the patient noticed a tender and moveable lump on collarbone. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events aching pain on injection site side of body(right), tender and moveable lump on collarbone were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651012
Sex: F
Age:
State: IL

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: brain fog; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6995) via an unspecified route of administration in the left arm on 23Apr2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included premenstrual dysphoria disorder and anxiety. The patient had no known allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Apr2021, the patient experienced brain fog for the whole day starting about 24 hours after receiving the vaccine, and the brain fog was gone the next day. The patient had no brain fog on the day she received the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event brain fog was resolved on 25Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651013
Sex: F
Age:
State: NM

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Distorted vision in right eye; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 29Apr2021 at 13:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 11:00, the patient experienced distorted vision in right eye. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event distorted vision in right eye was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651014
Sex: M
Age:
State: PA

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Name: Covid test; Result Unstructured Data: Test Result:Unknown; Comments: If covid tested post vaccination: Yes

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Patient contracted COVID four months after receiving PFE/BNT vaccine; Patient contracted COVID four months after receiving PFE/BNT vaccine; This is a spontaneous report from a contactable consumer via agency. An adult male patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in Dec2020 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no concomitant medications. Prior to vaccination the patient had not been diagnosed with COVID-19. It was reported the patient contracted COVID four months after receiving BNT162B2. It was reported the patient tested positive for COVID post-vaccination. It was unknown if treatment was received. The clinical outcomes of the events were unknown. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651015
Sex: F
Age:
State: PA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210429; Test Name: Body temperature; Result Unstructured Data: Test Result:99.1; Comments: low grade temp 99.1 within 2 hours of shot

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Itchy palms; Numbness in mouth; Tooth pain; Headache; Excessive thirst; Nausea; Joint pain throughout body; Lymph glands hurt; Low grade temp 99.1 within 2 hours of shot; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW9175) via an unspecified route of administration in the arm left on 29Apr2021 at 15:30(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2 (controlled with medication), undetermined autoimmune, mild hypothyroidism and mild hypertension. The patient has taken unspecified concomitant medications. The patient was known allergic to sulfa drugs, latex and cinnamon. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:30, the patient experienced itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 99.1(units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651016
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Shingles; rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line; Itching; Sensitivity; This is a spontaneous report from a non-contactable healthcare professional. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) on 09Apr2021 (at the age of 37-years-old) as a dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. On Apr2021, 1.5 days after the vaccination, the patient experienced rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line, some sensitivity and itching, shingles. Provider (Cancer Center) thought it might be shingles, another (Express Care) told patient to take BENADRYl and PEPCID. Therapeutic measures included cetirizine hydrochloride (ZYRTEC) as a result of events. The patient planned to use this if reaction occurred again. The clinical outcome of the events rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line, some sensitivity and itching, shingles was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1651017
Sex: F
Age:
State: CA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: dizziness; body aches; Nausea; chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 29Apr2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included diverticulitis and hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN) and levothyroxine sodium (SYNTHROID) both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0158) via an unspecified route of administration in left arm on 08Apr2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 21:00 the patient experienced nausea, dizziness, fever, chills and body aches which were lasting 15 hours or so. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of nausea, dizziness, fever, chills and body aches was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected. .

Other Meds: AUGMENTIN [AMOXICILLIN;CLAVULANIC ACID]; SYNTHROID

Current Illness:

ID: 1651018
Sex: M
Age:
State: NV

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: My knees, wrists, ankles and feet have started popping and cracking every day.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; My legs and feet used to get tired before however, this is extreme after shot and my joints are a new thing that was never an issue.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 08:30 (at the age of 52-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 08:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included overweight. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 03Apr2021 at 16:00, the patients knees, wrists, ankles and feet had started popping and cracking every day. The patient also experienced lower leg muscles cramp, feet tingled slightly towards the end of the day. Joints were very sore and swollen by the end of the day. The patient had to start having to use creams and take asprin or tylenol to calm them down and get to sleep. The patients legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue. The patient had not been able to find help on the subject of what should be done. Therapeutic measures were taken as a result of joints were very sore and swollen by the end of the day and included treatment with asprin or tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events knees, wrists, ankles and feet had started popping and cracking every day; lower leg muscles cramp, feet tingled slightly towards the end of the day; joints were very sore and swollen by the end of the day; legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651019
Sex: F
Age:
State: CA

Vax Date: 02/28/2021
Onset Date: 03/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; This is a spontaneous report from a contactable consumer, the patient. A 81-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6203) via an unspecified route of administration in the left arm on 28Feb2021 at 11:00 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism (reported as Thyroid hypo), cholesterol, ocular hypertension, and urinary incontinence. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy (reported as Codeine over sensitive). The patient had received other medication (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9261) via an unspecified route of administration in the left arm on 06Feb2021 at 12:00 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021 at 12:15, about two weeks after the second shot the patients tongue, roof of her mouth and throat started burning. Some days were better than others but the burning had not gone away. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events about two weeks after the second shot the patients tongue, roof of mouth and throat started burning; some days were better than others but the burning had not gone away, was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651020
Sex: F
Age:
State:

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: I feel terrible today. "I have 3 fingers on each hand will not bend and there is some numbness/Fingers are stiffening up; can't bed them; both hands; I feel terrible today/It is scaring her.; I am disabled and I can't walk; I just don't want to go to sleep tonight and not wake up; her fingers are stiffening up; she can't bend them they get stuck; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 73 years), dose 1 via an unspecified route of administration on 29Apr2021 as dose 1, single for covid-19 immunisation. The medical history and concomitant medications were not reported. The patient reported, she received her 1st Pfizer vaccine dose yesterday. She felt terrible today. She had 3 fingers on each hand would not bend and there was some numbness. These symptoms started a couple of hours after the vaccine dose. States she was disabled and can't walk. She just don't want to go to sleep tonight and not wake up. Says her fingers are stiffening up; she can't bend them they get stuck. States they get stuck like as if she was pointing. It is happening on bother her hands. States she has no idea what it is. It is scaring her. All the events occurred on 29Apr2021. The outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651021
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:High

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: High heart rate; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller stated she received the first dose of the Pfizer Covid 19 vaccine and she was experiencing now a high heart rate. She was asking to continue with the second dose or not. The patient underwent lab tests and procedures which included heart rate was high (unit not provided). The outcome of event was unknown. No follow up attempts are possible, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651022
Sex: M
Age:
State:

Vax Date: 04/21/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: left hand, left leg numbness; This is a spontaneous report from a contactable consumer or other non hcp reported for patient. A 33-years-old male patient received bnt162b2 (BNT162B2PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on 21Apr2021 as dose 1, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. The patient experienced left hand, left leg numbness on an unspecified date. The reporter asked if should see HCP or Emergency. The outcome of the event was reported as unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am